APA (7th ed.) Citation

Aierken, A., Li, B., Liu, P., Cheng, X., Kou, Z., Tan, N., . . . Wang, C. (2022). Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K/AKT signaling pathway. Stem Cell Research & Therapy, 13(1), 1. https://doi.org/10.1186/s13287-022-02832-0

Chicago Style (17th ed.) Citation

Aierken, Aili, et al. "Melatonin Treatment Improves Human Umbilical Cord Mesenchymal Stem Cell Therapy in a Mouse Model of Type II Diabetes Mellitus via the PI3K/AKT Signaling Pathway." Stem Cell Research & Therapy 13, no. 1 (2022): 1. https://doi.org/10.1186/s13287-022-02832-0.

MLA (9th ed.) Citation

Aierken, Aili, et al. "Melatonin Treatment Improves Human Umbilical Cord Mesenchymal Stem Cell Therapy in a Mouse Model of Type II Diabetes Mellitus via the PI3K/AKT Signaling Pathway." Stem Cell Research & Therapy, vol. 13, no. 1, 2022, p. 1, https://doi.org/10.1186/s13287-022-02832-0.